October 01, 2025
The medical device CMO and CDMO market size is is set to grow significantly, driven by evolving consumer prefe...
Read MoreNovember 01, 2025
The simulators market size is projected to expand from USD 14.72 billion in 2026 to USD 25.53 billion by 2034,...
Read MoreNovember 01, 2025
The anti-aging market size is expected to rise from USD 84.4 billion in 2026 to USD 129.88 billion by 2034, gr...
Read MoreNovember 01, 2025
The osteoarthritis therapeutics market size is expected to see growth from USD 11.92 billion in 2026 to USD 24...
Read MoreNovember 01, 2025
Projections indicate that, biological therapies industry is projected to rise from USD 458.47 billion in 2024 to USD 1107.66 billion by 2034, reflecting a CAGR of 9.35% over the next decade. The biological therapies market is rising due to the rising demand for personalized medicine. North America’s dominance can be attributed to the rising i...
November 01, 2025
According to market projections, the global analgesics market, valued at USD 43.8 billion in 2024, is anticipated to reach USD 80.26 billion by 2034, growing at a CAGR of 6.24% over the next decade. The rising prevalence of chronic pain and the availability of OTC drugs bolster market growth. North America dominated the global market due to the pre...
November 01, 2025
According to market projections, the pain management drugs sector is expected to grow from USD 84.1 billion in 2024 to USD 126.17 billion by 2034, reflecting a CAGR of 4.14%. The rising prevalence of chronic pain and growing research and development activities drive the global market. North America dominated the market due to the availability of st...
November 01, 2025
Based on market forecasts, the U.S. osteoarthritis therapeutics market, projected at USD 3.27 billion in 2024, is expected to reach USD 6.46 billion by 2034, growing at a CAGR of 7.14% over the forecast period. The severe disease burden, the limited efficacy of current therapies, and the demand for innovative solutions raise the importance of osteo...
November 01, 2025
Market insights predict, the osteoarthritis therapeutics industry is expected to grow from USD 9.95 billion in 2024 to USD 24.52 billion by 2034, driven by a CAGR of 9.45%. The rising prevalence of osteoarthritis is estimated to drive the growth of the market in the near future. North America led the global market owing to the high prevalence of os...
November 01, 2025
Market insights predict, the U.S. anti-aging industry is expected to grow from USD 20.21 billion in 2024 to USD 39.6 billion by 2034, driven by a CAGR of 6.95%. The U.S. anti-aging market is expanding due to growing demand for regenerative medicines as well as rising skincare awareness....
October 31, 2025
Market insights predict the global insulin analog industry will increase from USD 16.99 billion in 2024 to USD 25.29 billion by 2034, achieving a CAGR of 4.06%. The market expansion is driven by advances in analog formulation and delivery technologies. North America leads the market due to rising diabetes rates....
October 30, 2025
According to market projections, the global bispecific antibody market, valued at USD 11.97 billion in 2024, is anticipated to reach USD 460.23 billion by 2034, growing at a CAGR of 44.04% over the next decade. The bispecific antibody market is expanding due to increasing occurrences of cancer as well as rising developments. North America led the m...
October 29, 2025
According to market projections, the global pulmonary arterial hypertension drugs market, valued at USD 8.04 billion in 2024, is anticipated to reach USD 12.38 billion by 2034, growing at a CAGR of 4.44% over the next decade. The market is growing due to rising disease prevalence, improved diagnosis, and increasing demand for advanced targeted ther...
October 29, 2025
Market insights predict the global propofol injection industry will increase from USD 1.34 billion in 2024 to USD 2.64 billion by 2034, achieving a CAGR of 7.14%. The increasing number of surgeries and growing research and development activities drive the global market. North America dominated the market due to a robust healthcare infrastructure an...